{"cik":1576885,"entityName":"Acumen Pharmaceuticals, Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-08-13","val":40468087,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-11-15","val":40470323,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q4I"}]}}},"us-gaap":{"AccountsPayableAndOtherAccruedLiabilitiesCurrent":{"label":"Accounts Payable and Other Accrued Liabilities, Current","description":"Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":423000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":423000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":1611000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":1107000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":531000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":531000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":2907000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":382000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AccruedProfessionalFeesCurrent":{"label":"Accrued Professional Fees, Current","description":"Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":200000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":200000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":506000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":8374000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":8374000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":9241000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":352606000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":77000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":38000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":116000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":39000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":253000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":127000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":557000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":304000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":77000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":38000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":116000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":39000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":253000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":127000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":557000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":304000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":44429000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":44429000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":72943000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":234849000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":44429000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":44429000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":70572000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":204913000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AssetsFairValueDisclosure":{"label":"Assets, Fair Value Disclosure","description":"Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":36758000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":36758000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":36766000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":228872000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2019-12-31","val":6552000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2019-12-31","val":6552000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2019Q4I"},{"end":"2020-06-30","val":3242000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2I"},{"end":"2020-09-30","val":1959000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2020-12-31","val":43777000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":43777000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":68812000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":135802000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect","description":"Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-3310000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":-4593000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":25035000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":92025000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"CashEquivalentsAtCarryingValue":{"label":"Cash Equivalents, at Carrying Value","description":"Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":36800000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":36800000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":36800000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":134800000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":0.0001,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":0.0001,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-07-06","val":0.0001,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"end":"2021-09-30","val":0.0001,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":50500000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":50500000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":50500000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":300000000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":419124,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":419124,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":556570,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":40470323,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":419124,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":419124,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":556570,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":40470323,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ConversionOfStockSharesConverted1":{"label":"Conversion of Stock, Shares Converted","description":"\"The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"\"Part noncash\"\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.\"","units":{"shares":[{"start":"2020-01-01","end":"2020-06-30","val":9853193,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-06-30","val":32145520,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"}]}},"DeferredCosts":{"label":"Deferred Costs, Noncurrent","description":"Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.","units":{"USD":[{"end":"2021-06-30","val":2352000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-06-30","val":-9.73,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":-4.86,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":-15.68,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-5.94,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-207.52,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":-141.93,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-7,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-0.1,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"EmployeeRelatedLiabilitiesCurrent":{"label":"Employee-related Liabilities, Current","description":"Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2021-06-30","val":600000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":797000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings":{"label":"Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings","description":"Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":81157000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":81157000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues":{"label":"Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances","description":"Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":81190000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":81190000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements":{"label":"Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements","description":"Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":-5380000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":-5380000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue":{"label":"Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value","description":"Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.","units":{"USD":[{"end":"2020-12-31","val":5413000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":5413000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":0,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":481000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":259000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":707000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":226000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":2402000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":1187000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":4537000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":2135000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"GrantsReceivableCurrent":{"label":"Grants Receivable, Current","description":"Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":109000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":109000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":109000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":109000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"IncreaseDecreaseInAccountsPayable":{"label":"Increase (Decrease) in Accounts Payable","description":"The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":380000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":1231000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":741000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":-149000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities","description":"Amount of increase (decrease) in accrued expenses, and obligations classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":147000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":734000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":691000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":685000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInOtherOperatingAssets":{"label":"Increase (Decrease) in Other Operating Assets","description":"Amount of increase (decrease) in operating assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":270000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":378000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":13000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":13000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-406000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":-461000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":1108000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":4297000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"InvestmentIncomeInterest":{"label":"Investment Income, Interest","description":"Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":1000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":1000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":8000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":4000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":45000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":37000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":6367000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":6367000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":4518000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":1489000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":44429000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":44429000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":72943000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":234849000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"LiabilitiesFairValueDisclosure":{"label":"Financial and Nonfinancial Liabilities, Fair Value Disclosure","description":"Fair value of financial and nonfinancial obligations.","units":{"USD":[{"end":"2020-12-31","val":5413000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":5413000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":31675000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":200456000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":-6000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":-94109000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-3310000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":-4593000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":-6634000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":-14322000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-4080000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":-2035000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":-6570000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-2490000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-88355000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":-61358000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-92257000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-3902000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"NonoperatingIncomeExpense":{"label":"Nonoperating Income (Expense)","description":"The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":1000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":1000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":-81121000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":-57917000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-81088000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":33000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":4458000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":2186000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":7678000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":3220000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":7234000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":3441000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":11169000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":3935000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":-4081000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":-2035000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":-6571000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-2490000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":-7234000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":-3441000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-11169000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-3935000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"OtherAccruedLiabilitiesCurrent":{"label":"Other Accrued Liabilities, Current","description":"Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":90000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":90000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":52000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":119000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"OtherAssetsNoncurrent":{"label":"Other Assets, Noncurrent","description":"Amount of noncurrent assets classified as other.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q4I"},{"end":"2021-06-30","val":13000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":13000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"OtherNonoperatingIncomeExpense":{"label":"Other Nonoperating Income (Expense)","description":"Amount of income (expense) related to nonoperating activities, classified as other.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":28000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":19000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":47000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":19000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"PaymentsToAcquireProductiveAssets":{"label":"Payments to Acquire Productive Assets","description":"The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":6000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":14000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":543000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":543000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":1651000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":4840000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceOfConvertiblePreferredStock":{"label":"Proceeds from Issuance of Convertible Preferred Stock","description":"The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.","units":{"USD":[{"start":"2021-01-01","end":"2021-06-30","val":30031000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":30031000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"PropertyPlantAndEquipmentNet":{"label":"Property, Plant and Equipment, Net","description":"Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.","units":{"USD":[{"end":"2021-06-30","val":6000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":13000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":3977000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":1927000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":6971000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":2994000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":4832000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":2254000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":6632000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":1800000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-26965000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":-26965000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":-115320000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":-119222000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":77000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":116000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":253000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":557000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":-11420000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2019-12-31","val":-11420000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-13426000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q1I"},{"end":"2020-06-30","val":-15423000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-06-30","val":-15423000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q2I"},{"end":"2020-09-30","val":-17874000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-18591000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":-18591000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-45462000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q1I"},{"end":"2021-06-30","val":-106079000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2021-06-30","val":-106079000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2I"},{"end":"2021-09-30","val":233360000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"StockIssuedDuringPeriodSharesPeriodIncreaseDecrease":{"label":"Stock Issued During Period, Shares, Period Increase (Decrease)","description":"The increase (decrease) during the period in the number of shares issued.","units":{"shares":[{"end":"2021-07-06","val":39911517,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2021-07-06","val":39911517,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2I"}]}},"TemporaryEquityCarryingAmountAttributableToParent":{"label":"Temporary Equity, Carrying Amount, Attributable to Parent","description":"Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.","units":{"USD":[{"end":"2020-12-31","val":56653000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":56653000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":174504000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"}]}},"TemporaryEquityLiquidationPreference":{"label":"Temporary Equity, Liquidation Preference","description":"The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"USD":[{"end":"2020-12-31","val":62984000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":62984000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":94280000,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"}]}},"TemporaryEquitySharesAuthorized":{"label":"Temporary Equity, Shares Authorized","description":"The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"shares":[{"end":"2020-12-31","val":42066830,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":42066830,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":42066830,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"}]}},"TemporaryEquitySharesIssued":{"label":"Temporary Equity, Shares Issued","description":"The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"shares":[{"end":"2020-12-31","val":19877219,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":19877219,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":28232672,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"}]}},"TemporaryEquitySharesOutstanding":{"label":"Temporary Equity, Shares Outstanding","description":"The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.","units":{"shares":[{"end":"2020-12-31","val":19877219,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":19877219,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":28232672,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"}]}},"UnrecognizedTaxBenefits":{"label":"Unrecognized Tax Benefits","description":"Amount of unrecognized tax benefits.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"end":"2020-12-31","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-06-30","val":0,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense":{"label":"Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense","description":"Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.","units":{"USD":[{"start":"2020-01-01","end":"2020-06-30","val":0,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-06-30","val":0,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-01","end":"2020-06-30","val":419124,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2020-04-01","end":"2020-06-30","val":419124,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":419124,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":419124,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-06-30","val":425761,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16"},{"start":"2021-04-01","end":"2021-06-30","val":432325,"accn":"0001193125-21-247879","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-16","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":13177983,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":38266593,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"AccretionAmortizationOfDiscountsAndPremiumsInvestments":{"label":"Accretion (Amortization) of Discounts and Premiums, Investments","description":"The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":-21000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"AccumulatedOtherComprehensiveIncomeLossNetOfTax":{"label":"Accumulated Other Comprehensive Income (Loss), Net of Tax","description":"Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.","units":{"USD":[{"end":"2021-09-30","val":-28000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":9853193,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-01-01","end":"2021-09-30","val":3662365,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2021-09-30","val":4000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ComprehensiveIncomeNetOfTax":{"label":"Comprehensive Income (Loss), Net of Tax, Attributable to Parent","description":"Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-6570000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2020-07-01","end":"2020-09-30","val":-2490000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-92285000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-3930000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"Depreciation":{"label":"Depreciation","description":"The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":1000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":{"label":"Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount","description":"Amount of cost to be recognized for option under share-based payment arrangement.","units":{"USD":[{"end":"2021-09-30","val":3100000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"InterestExpense":{"label":"Interest Expense","description":"Amount of the cost of borrowed funds accounted for as interest expense.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":23000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":23000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"InterestIncomeDebtSecuritiesAvailableForSaleOperating":{"label":"Interest Income, Debt Securities, Available-for-sale, Operating","description":"Amount of interest income, amortization of premium and accretion of discount on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale); classified as operating.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":27000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"MarketableSecuritiesCurrent":{"label":"Marketable Securities, Current","description":"Amount of investment in marketable security, classified as current.","units":{"USD":[{"end":"2021-09-30","val":64162000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"MarketableSecuritiesNoncurrent":{"label":"Marketable Securities, Noncurrent","description":"Amount of investment in marketable security, classified as noncurrent.","units":{"USD":[{"end":"2021-09-30","val":29910000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax":{"label":"OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax","description":"Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":-28000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":-28000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"PaymentsToAcquireMarketableSecurities":{"label":"Payments to Acquire Marketable Securities","description":"Amount of cash outflow for purchase of marketable security.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":94095000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-07-06","val":0.0001,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2I"},{"end":"2021-09-30","val":0.0001,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-07-06","val":10000000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q2I"},{"end":"2021-09-30","val":10000000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PreferredStockSharesIssued":{"label":"Preferred Stock, Shares Issued","description":"Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PreferredStockSharesOutstanding":{"label":"Preferred Stock, Shares Outstanding","description":"Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"PrepaidInsurance":{"label":"Prepaid Insurance","description":"Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":5000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2299000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":168559000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ProceedsFromStockOptionsExercised":{"label":"Proceeds from Stock Options Exercised","description":"Amount of cash inflow from exercise of option under share-based payment arrangement.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":2000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ReclassificationsOfTemporaryToPermanentEquity":{"label":"Reclassifications of Temporary to Permanent Equity","description":"The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":174504000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":174504000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":2663084,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value","description":"Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.","units":{"USD":[{"end":"2021-09-30","val":51591000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":1001517,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":3662365,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2020-12-31","val":1.13,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1.92,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value","description":"Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"USD":[{"end":"2021-09-30","val":14034000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number","description":"Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"shares":[{"end":"2021-09-30","val":958709,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price","description":"Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"USD/shares":[{"end":"2021-09-30","val":1.38,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price","description":"Weighted average price at which option holders acquired shares when converting their stock options into shares.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-09-30","val":0.72,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-09-30","val":2.21,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value","description":"Weighted average grant-date fair value of options vested.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-09-30","val":1.34,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"StockIssuedDuringPeriodSharesStockOptionsExercised":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period","description":"Number of share options (or share units) exercised during the current period.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":2236,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":168559000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":168559000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}},"StockIssuedDuringPeriodValueStockOptionsExercised":{"label":"Stock Issued During Period, Value, Stock Options Exercised","description":"Value of stock issued as a result of the exercise of stock options.","units":{"USD":[{"start":"2021-01-01","end":"2021-09-30","val":2000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"start":"2021-07-01","end":"2021-09-30","val":2000,"accn":"0001193125-21-329068","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3"}]}}}}}